Biomarin Pharmaceutical Inc
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 4,746 | 0.0% | 79,859 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 3,826 | 0.0% | 70,636 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 1,521 | 0.0% | 27,670 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 3,555 | 0.0% | 50,291 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 2,419 | 0.0% | 36,797 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 4,041 | 0.0% | 57,486 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 1,288 | 0.0% | 15,641 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 11,965 | 0.0% | 136,989 | 3/31/2024 |
| 2023 Q4 | 2/16/2024 | 12,531 | 0.0% | 129,966 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 13,395 | 0.0% | 151,387 | 9/30/2023 |
| 2023 Q2 | 5/17/2024 | 8,267 | 0.0% | 95,376 | 6/30/2023 |
| 2023 Q1 | 5/17/2024 | 12,911 | 0.0% | 132,774 | 3/31/2023 |
| 2022 Q4 | 5/17/2024 | 21,533 | 0.0% | 208,066 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 16,426 | 0.0% | 193,785 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 12,677 | 0.0% | 152,979 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 9,611 | 0.0% | 124,656 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 10,488 | 0.0% | 117,742 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 9,329 | 0.0% | 120,711 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 8,960 | 0.0% | 107,392 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 4,896 | 0.0% | 64,854 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 5,646 | 0.0% | 64,854 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 3,043 | 0.0% | 40,000 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 4,934 | 0.0% | 40,000 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 3,380 | 0.0% | 40,000 | 3/31/2020 |
| 2019 Q4 | 3/12/2020 | 3,384 | 0.0% | 40,000 | 12/31/2019 |